WAGR syndrome. A case history;Sindrome de WAGR. A proposito de un caso

Anales Espanoles de Pediatria

Volumn 49, Issue 4, 1998, Pages 381-387

  Moreno Garcia M ^a,b   Sanchez Del Pozo J ^a   Fernandez Martinez F J ^a   Moreno Izquierdo, A ^a   Barreiro Miranda, E ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Servicio de Pediatría ^*  (Spain)

Author keywords

Aniridia; Microdeletion syndromes; WAGR; Wilms' tumor

Indexed keywords

ADULT; ANIRIDIA; ARTICLE; CASE REPORT; CHROMOSOME 11P; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CLINICAL FEATURE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPE; LYMPHOCYTE CULTURE; MALE; MENTAL DEFICIENCY; NEPHROBLASTOMA; UROGENITAL TRACT MALFORMATION; WAGR SYNDROME; CHROMOSOME 11; GENETICS; KARYOTYPING; NEWBORN;

CHROMOSOMES, HUMAN, PAIR 11; HUMANS; INFANT, NEWBORN; KARYOTYPING; MALE; WAGR SYNDROME;

EID: 0032175174     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Miller RW, Fraumeni JF, Manning MD. Association of Wilms' tumor with aniridia, hemihypertrophy and other congenital malformations. New Engl J Med 1964; 270:922-927.
2. Ivanov I, Shuper A, Shohat M, Snir M, Weitz R. Aniridia: recent achievements in paediatric practice. J Pediatr 1995; 154:795-800.
3. Marlin S, Couct D, Lacombc D, Ccssans C, Bonneau D. Obesity: a new feature of WAGR (del 11p) syndrome. Clin Dysmorphol 1994; 3:255-257.
4. Mathur P, Khamesera HL, Pendse AK, Chittora R, Porewal KK. Wilm's tumour with WAGR complex. Indian J Cancer 1996; 33:136-138.
5. Martínez-Mora J, Audi L, Toran N, Isnar R, Casteliu A, Iribinae MP, Egozcue J. Ambiguous genitalia, gonadoblastoma, aniridia and mental retardation with deletion of chromosome 11. J Urol 1989; 142:1298-1300.
6. Gracia R, Nieto JA, Nistal M, Iturriaga R, Lledo G, Barrio R, Lama R. Asociación de aniridia con tumor cmbrionario no renal (gonadoblastoma) en niño con síndrome de Smith-Lemli-Opitz. An Esp Ped 1976; 9:19-24.
7. Smith ACM, Sujansky E, Riccardi VM. Aniridia, mental retardation and genital abnormality in two patients with 46,XY,11p-. Birth Defects 1977; 13:257-261.
8. Beckwith JB. Precursor lesions of Wilms's tumor. Clinical and biological implications. Med Pediatr Oncol 1993; 21:158-168.
9. Ariel I, Abeliovich D, Bar-ziv J, Hochberg A. Renal pathology in WAGR syndrome. Pediatr Pathol Lab Med 1996; 16:1013-1021.
10. Nicholson HS, Blask AN, Markle BM, Reaman GH, Byrne J. Uterine anomalies in Wilm'tumor survivors. Cancer 1996; 78:887-891.
11. Matsunaga E. Genetics of Wilms's tumor. Hum Genet 1981; 57:231-246.
12. Haber DA, Buckler AJ, Glaser T et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms'tumor. Cell 1990; 61:1257-1269.
13. Fantes JA, Bickmore WA, Fletcher JM, Ballesta F, Hanson IM, van-Heyningen V. Submmicroscopic deletions at the WAGR locus, reveales by nonradiactive in situ hybridization. Am J Hum Genet 1992; 51:1286-1294.
14. Huff V, Meadows A, Riccardi VM, Strong LC, Saunders GF. Parental origin of de novo constitutional deletions of chromosome band 11p13. Am J Hum Genet 1990; 47:155-160.
15. Puissant H, Azoulay M, Serre JL, Piet L, Junien C. Molecular analysis of a reciprocal translocation t(5;11)(q1;p13) in a WAGR patient. Hum Genet 1988; 79:280-282.
16. Pettenati MJ, Weaver RG, Burton BK. Translocation of t(5;11) (q13.1;p13) associated with familial issolated aniridia. Am J Med Genet 1989; 34:230-232.
17. Crolla JA, Cawdery JE, Oley CA, Young ID, Gray J, Fantes J, van Heyningen V. A FISH approach to defining the extent and possible clinical significance of deletions at the WAGR locus. J Med Genet 1997; 34:207-212.
18. Wadey RB, Pal N, Buckle B, Yeomans E, Pritchard J, Cowell JK. Loss of heterozygosity in Wilm's tumour involves two distinct region of chromosome 11. Oncogene 1990; 5:901-907.
19. Gessler M, Koning A, Bruns GA. The genomic organization and expression of the WT1 gene. Genomic 1992; 12:807-813,
20. Bonetta L, Kuehn SE, Huang A et al. Wilm's tumor locus on 11p13 defined by multiple CpG island-associated transcripts. Science 1990; 250:994-997.
21. Haber DA, Housman DE. Role of the WT1 gene in Wilms'tumour. Cancer Surv 1992; 12:105-117.
22. Rauscher FJ. The WT1 Wilms tumor gene product: A developementally regulated transcription factor in the kidney that functions as a tumor suppresor. FASEBJ 1993; 7:896-903.
23. Little MH, Prosser J, Condie A, Smith PJ, Van Heyningen V, Hastie ND. Zinc finger point mutations whitin the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci USA 1992; 89:4791-4795.
24. Kaplinsky C, Ghahremani M, Frishberg Y, Rechavi G, Pelletier J. Familial Wilms'tumor associated with a WT1 zinc finger mutation. Genomic 1996; 38:451-453.
25. Little M, Wells C. A clinical overview of WT1 gene mutations. Hum Mutat 1997; 9:209-225.
26. Park S, Schhalling M, Bernard A et al. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 1993; 4:415-420.
27. Pritchart K, Renshaw J, King L. The Wilms tumour (WT1) gene is mutated in a secondary leukemia in a WAGR patient. Hum Mol Genet 1994; 3:1633-1637.
28. Hoovers JM, Kalikin LM. Johnson LA et al. Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoint and subcromosomal transferable fragments. Proc Natl Acad Sci 1995; 92:12456-12460.
29. Weksberg R, Shen DR, Fei YL, Song QL, Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet 1993; 5:143-150.
30. Lee MP, Hu RJ, Johnson LA, Feinberg AP. Human KVLQT1 gene shows tissue-specific imprinting and encompases Beckwith-Wiemann syndrome chromosomal rearrangements. Nat Genet 1997; 15:181-185.
31. Giannoukakis N, Deal C, Paquette J, Goodyear CG, Polychronatos C. Parental imprinting of the human IGF2 gene. Nat Genet 1993; 4:98-101.
32. Catchpoole D, Lam WW, Valler D, Temple IK, Joyce JA, Reik W, Schofield PN, Maher ER. Epigenetic modification and uniparental inherence of H19 in Beckwith-Wiedemann syndrome. J Med Genet 1997; 34:353-359.
33. Hatada I, Inazawa J, Abe T et al. Genomic imprinting of human p57KIP2 and its reduced expression in Wilms tumors. Hum Mol Genet 1996; 5:783-788.
34. Weng EY, Mortier GR, Graham JM Jr. Beckwith-Wiedemann syndrome: An update and review for the primary pediatrician. Clin Pediatr 1995; 34:317-326.
35. Maw MA, Grunddy PE, Millow LJ et al. A third Wilms's tumor locus on chromosome 16q. Cancer Res 1992; 52:3094-3098.
36. Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC. Loss of heterozygosity for chromosome 16q and 1p in Wilms's tumor predicts and adverse outcome. Cancer Res 1994; 54:2331-1333.
37. Grundy P, Coppes MJ, Haber D. Molecular genetics of Wilms tumor. Hematol Oncol Clin North Am 1995; 9:1201-1215.
38. Besnard-Guerin, Newsham I, Winqvist R, Cavenee WK. A common region of loss of heterozygosity in Wilms's tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5. Hum Genet 1996; 97:163-170.
39. Gerald WL.The molecular genetics of Wilms tumor: a paradigm of heterogenneity in tumor development. Cancer Invest 1994; 12:350-359.
40. Glaser T, Walton DS, Mas RL. Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nature Genetics 1992; 2:232-239.
41. Ton CCT, Hirvonen H, Miwa H et al. Positional cloning and characterization of a paired box-and homeobox-containing gene from the aniridia region. Cell 1991; 67:1059-1074.
42. Hanson IM, Seawright A, Hardman K, Hodgson S, Zaletayed D, Fekete G, Van Heyningen V. PAX6 mutations in aniridia. Hum Mol Genet 1993; 2:915-920.
43. Jordan T, Hanson I, Zaletayed D et al. The human PAX6 gene is mutated in two patients with aniridia. Nature Genet 1992; 1:328-332.
44. Martha AD, Ferrell RE, Mintz H, Lyons L, Saunders GF. Paired box mutations in familial and sporadic aniridia predicts truncated aniridia proteins. Am J Hum Genet 1994; 54:801-811.
45. Drechsler M, Royer B. A LINE element is present at the site of a 300 kb deletion starting in intron 10 of the PAX6 gene in a case of familial aniridia. Hum Genet 1996; 98:297-303.
46. Glaser T, Jepeal L, Edward JG, Young SR, Favor J, Mass RL. PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia an central nervous system defects. Nature Genetics 1994; 7:463-471.
47. Hanson IM, Fletcher JM, Jordan T et al. Mutations at the PAX6 locus are found in hetrogeneous anterior segment malformations including Peter's anomaly. Nature Genet 1994; 6:168-173.
48. van Heyningen V, Bickmore WA, Seawright A et al. Role for the tumor gene in genital development?. Proc Natl Acad Sci 1990; 87:5383-5386.
49. Kreidber JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R. WT-1 is requires for early kidney development. Cell 1993; 74:679-691.
50. Schumacher V, Schneider S, Figge A et al. Correlation of germ-line mutations ans two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci 1997; 94:3972-3977.
51. Bruening W, Bardeessy N, Silverman BL et al. Germline intronic and exoninc mutations in the Wilms'tumour gene (WT1) affecting urogenital development. Nature Genet 1992; 1:144-148.
52. Pelletier J, Brueniing W, Li FP, Haber DA, Glaaser T, Housman DE. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 1991; 353:431-434.
53. Little M, Holmes G, Bickmore W, van Heyningen V, Hastie N, Wainwright B. DNA binding capacity of the WT1 protein abolished by Denys-Drash syndrome WT1 point mutation. Hum Mol Genet 1995; 4:351-358.
54. Little MH, Williamson KA, Mannens M, Kelsey A, Gosden C, Hastie ND, van Heyningen V. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Molec Genet 1993; 2:259-264.
55. Schwartz F, Neve R, Eisenman R, Gessler M, Bruns GAP. A WAGR region gene between PAX6 and FSHB expressed in fetal brain. Hum Genet 1994; 94:658-664.
56. Schwartz F, Eisenman R, Knoll J, Gessler M, Bruns G. cDNA sequence, genomic organization, and evolutionary conservation of a novel gene from the WAGR region. Genomic 1995; 29:526-532.
57. Gessler M, Thomas GH, Coullin P et al. A deletion map of the WAGR region on chromosome 11. Am J Hum Genet 1989; 44:486-495.
58. Hanson IM, Seawright A, van heyningen V. The human BDNF gene maps between FSHB and HVBS1 at the boundary of 11p13-p14. Genomic 1992; 13:1331-1333.
59. Fantes JA, Oghene K, Boyle S et al. A high-resolution integrated physical, cytogenetic, and genetic map of human chromosome 11: distal p13 to proximal p15.1. Genomic 1995; 25:447-461.
60. Drechsler M, Meijers EJ, Schneider S et al. Molecular analysis of aniridia patients for deletions involving the Wilms'tumor. Hum Genet 1994; 94:331-338.
61. Berber JC, Mahl H, Porch J, Crawfurd MD. Interstitial deletions without phenotypic effect: prenatal diagnosis of a new family and brief review. Prenat Diagn 1991, 11:411-416.